Efavirenz As a Psychotropic Drug
European Review for Medical and Pharmacological Sciences 2020; 24: 10729-10735 Efavirenz as a psychotropic drug N. ZAREIFOPOULOS1, M. LAGADINOU1, A. KARELA1, F. POULIASI1, I. ECONOMOU1, A. TSIGKOU2, D. VELISSARIS1,3 1Emergency Department, University Hospital of Patras, Patras, Greece 2Department of Architecture, University of Patras, Patras, Greece 3Department of Internal Medicine, University of Patras School of Medicine, Patras, Greece Abstract. – OBJECTIVE: Antiretroviral drugs Introduction are the mainstay of treatment for human immu- nodeficiency virus (HIV) infection. Lifelong high- Neuropsychiatric adverse effects are a common ly active antiretroviral therapy (HAART) is in- occurrence in daily clinical practice, and they are dicated to prevent disease progression to ac- quired immunodeficiency syndrome (AIDS). Efa- frequently observed even during treatment with virenz was a first-line component of HAART drugs that would not be expected to affect the ner- across the world for many years. The purpose vous system. Antimicrobial agents have been asso- of this article is to review the psychotropic prop- ciated with neuropsychiatric adverse effects which erties of efavirenz, which are the most import- may be severe, but this rarely affects prescribing ant adverse events associated with the drug and practices and guidelines1. This is to be expected as commonly result in treatment discontinuation. MATERIALS AND METHODS: A PubMed infectious diseases are life-threatening, whereas search was conducted using efavirenz as a the typically reversible psychotropic side effects search term, which returned 4655 results. Titles of antimicrobial agents are not; and the drugs in- and abstracts of articles were screened for rele- dicated are extremely effective, perhaps more so vance, and all relevant articles published in En- than any other class of drugs for its specific indi- glish were included in the narrative review.
[Show full text]